Zealand Pharma AS (ZLDPF)
116.06
-4.12
(-3.43%)
USD |
OTCM |
Nov 13, 16:00
Zealand Pharma Debt to Equity Ratio: 0.0316 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.0316 |
| June 30, 2024 | 0.0295 |
| March 31, 2024 | 0.0961 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.5833 |
| December 31, 2022 | 0.3931 |
| September 30, 2022 | 1.006 |
| June 30, 2022 | 0.7091 |
| March 31, 2022 | 0.9327 |
| December 31, 2021 | 0.6983 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.4536 |
| March 31, 2018 | 0.3069 |
| December 31, 2017 | 0.2637 |
| September 30, 2017 | 0.2221 |
| June 30, 2017 | 0.8046 |
| March 31, 2017 | 0.6391 |
| December 31, 2016 | 1.194 |
| September 30, 2016 | 1.434 |
| June 30, 2016 | 2.894 |
| March 31, 2016 | 1.690 |
| December 31, 2015 | 1.241 |
| September 30, 2015 | 2.090 |
| June 30, 2015 | 1.847 |
| March 31, 2015 | 1.476 |
| December 31, 2014 | 1.076 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
1.006
Maximum
Sep 2022
0.224
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Novo Nordisk AS | 0.4727 |
| Genmab AS | 0.00 |
| Ascendis Pharma AS | -2.095 |
| Galecto Inc | -- |
| Evaxion Biotech AS | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.442B |
| Total Liabilities (Quarterly) | 111.84M |
| Shareholders Equity (Quarterly) | 1.331B |
| Current Ratio | 35.49 |
| Net Debt Paydown Yield | -0.10% |